These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 6965594)
21. [Participation of von Willebrand factor in blood platelet functions]. Mikami S; Takahashi Y; Nishino M; Fukui H Nihon Rinsho; 1978 Dec; 36(12):3824-9. PubMed ID: 372620 [No Abstract] [Full Text] [Related]
22. Factor VIII (Willebrand) antigen and ristocetin-Willebrand factor in pigs with von Willebrand's disease. Fass DN; Brockway WJ; Owen CA; Bowie EJ Thromb Res; 1976 Mar; 8(3):319-27. PubMed ID: 1083569 [No Abstract] [Full Text] [Related]
23. Factor VIII/von Willebrand factor binding to von Willebrand's disease platelets. Gralnick HR; Williams SB; Shafer BC; Corash L Blood; 1982 Aug; 60(2):328-32. PubMed ID: 6807372 [TBL] [Abstract][Full Text] [Related]
24. von Willebrand factor: characterization of interaction among von Willebrand factor, ristocetin and platelet. Hashimoto S; Suzuki K Nihon Ketsueki Gakkai Zasshi; 1979 Dec; 42(6):851-63. PubMed ID: 317771 [No Abstract] [Full Text] [Related]
25. Identical binding site on human platelets for von Willebrand factor and bovine platelet aggregating factor. Suzuki K; Nishioka J; Hashimoto S Thromb Res; 1980 Jan 1-15; 17(1-2):215-23. PubMed ID: 6769177 [No Abstract] [Full Text] [Related]
26. von Willebrand factor. A protein which binds at the cell surface interface between platelets. Senogles SE; Nelsestuen GL J Biol Chem; 1983 Oct; 258(20):12327-33. PubMed ID: 6605342 [TBL] [Abstract][Full Text] [Related]
27. Hydrolysis of human platelet membrane glycoproteins with a Serratia marcescens metalloprotease: effect on response to thrombin and von Willebrand factor. Cooper HA; Bennett WP; White GC; Wagner RH Proc Natl Acad Sci U S A; 1982 Mar; 79(5):1433-7. PubMed ID: 7041120 [TBL] [Abstract][Full Text] [Related]
28. Inhibition of Willebrand factor in von Willebrand disease. Maragall S; Castillo R; Ordinas A; Liendo F; Rodríguez M Thromb Res; 1979; 14(2-3):495-500. PubMed ID: 312541 [No Abstract] [Full Text] [Related]
29. Polybrene-induced platelet agglutination and reduction in electrophoretic mobility: enhancement by von Willebrand factor and inhibition by vancomycin. Coller BS Blood; 1980 Feb; 55(2):276-81. PubMed ID: 6766335 [TBL] [Abstract][Full Text] [Related]
30. Platelets fixed with paraformaldehyde: a new reagent for assay of von Willebrand factor and platelet aggregating factor. Allain JP; Cooper HA; Wagner RH; Brinkhous KM J Lab Clin Med; 1975 Feb; 85(2):318-28. PubMed ID: 234499 [TBL] [Abstract][Full Text] [Related]
31. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers. Weiss HJ; Meyer D; Rabinowitz R; Pietu G; Girma JP; Vicic WJ; Rogers J N Engl J Med; 1982 Feb; 306(6):326-33. PubMed ID: 6798442 [TBL] [Abstract][Full Text] [Related]
32. Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand's disease. Jenkins CS; Phillips DR; Clemetson KJ; Meyer D; Larrieu MJ; Lüscher EF J Clin Invest; 1976 Jan; 57(1):112-24. PubMed ID: 1081991 [TBL] [Abstract][Full Text] [Related]
33. Von Willebrand factor, polycations, and platelet agglutination. Rosborough TK Thromb Res; 1980 Feb 1-15; 17(3-4):481-90. PubMed ID: 6966084 [No Abstract] [Full Text] [Related]
34. Four agglutination assays evaluated for measurement of von Willebrand factor (ristocetin cofactor activity). Ermens AA; de Wild PJ; Vader HL; van der Graaf F Clin Chem; 1995 Apr; 41(4):510-4. PubMed ID: 7720238 [TBL] [Abstract][Full Text] [Related]
35. Platelet receptors for human Factor VIII/von Willebrand protein: functional correlation of receptor occupancy and ristocetin-induced platelet aggregation. Kao KJ; Pizzo SV; McKee PA Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5317-20. PubMed ID: 315561 [TBL] [Abstract][Full Text] [Related]
36. Interaction of asialo von Willebrand factor with glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and mediates platelet aggregation. De Marco L; Girolami A; Russell S; Ruggeri ZM J Clin Invest; 1985 Apr; 75(4):1198-203. PubMed ID: 3157702 [TBL] [Abstract][Full Text] [Related]
37. Plasma and platelet von Willebrand factor defects in uremia. Gralnick HR; McKeown LP; Williams SB; Shafer BC; Pierce L Am J Med; 1988 Dec; 85(6):806-10. PubMed ID: 3264111 [TBL] [Abstract][Full Text] [Related]
38. A rapid, automated VWF ristocetin cofactor activity assay improves reliability in the diagnosis of Von Willebrand disease. Bowyer AE; Shepherd F; Kitchen S; Makris M Thromb Res; 2011 Apr; 127(4):341-4. PubMed ID: 21186048 [TBL] [Abstract][Full Text] [Related]
39. The effects of ristocetin and von Willebrand factor on platelet electrophoretic mobility. Coller BS J Clin Invest; 1978 May; 61(5):1168-75. PubMed ID: 307006 [TBL] [Abstract][Full Text] [Related]
40. Nature of von Willebrand factor: a new assay and a specific inhibitor. Sarji KE; Stratton RD; Wagner RH; Brinkhous KM Proc Natl Acad Sci U S A; 1974 Aug; 71(8):2937-41. PubMed ID: 4547258 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]